APA (7th ed.) Citation

M, Y., S, F., AKA, A., SJ, W., MG, A., SP, P., . . . A, T. (2026). One vs. 2 vs. ≥3 TET2 mutations in chronic myelomonocytic leukemia: Co-mutation patterns and prognostic relevance in the context of contemporary prognostic models including BLAST-mol and CPSS-mol. Blood cancer journal, 16(1), . https://doi.org/10.1038/s41408-026-01500-3

Chicago Style (17th ed.) Citation

M, Yousuf, et al. "One Vs. 2 Vs. ≥3 TET2 Mutations in Chronic Myelomonocytic Leukemia: Co-mutation Patterns and Prognostic Relevance in the Context of Contemporary Prognostic Models Including BLAST-mol and CPSS-mol." Blood Cancer Journal 16, no. 1 (2026). https://doi.org/10.1038/s41408-026-01500-3.

MLA (9th ed.) Citation

M, Yousuf, et al. "One Vs. 2 Vs. ≥3 TET2 Mutations in Chronic Myelomonocytic Leukemia: Co-mutation Patterns and Prognostic Relevance in the Context of Contemporary Prognostic Models Including BLAST-mol and CPSS-mol." Blood Cancer Journal, vol. 16, no. 1, 2026, https://doi.org/10.1038/s41408-026-01500-3.